World News

What is De-escalation Treatment in Cancer Research?

Ogkologos - 30 Μαΐου, 2023

Could food improve cancer treatment? – That Cancer Conversation

Ogkologos - 30 Μαΐου, 2023

Significant PFS Benefit in Patients with HR-positive, HER2-negative MBC Who Switched...

Ogkologos - 26 Μαΐου, 2023

Use of Immune Checkpoint Inhibitors is Safe and Effective in Patients...

Ogkologos - 26 Μαΐου, 2023

Reunión anual de la American Society of Clinical Oncology de 2023:...

Ogkologos - 25 Μαΐου, 2023

ASCO Annual Meeting 2023: Improving Patients’ Lives Through Collaboration, Research, and...

Ogkologos - 25 Μαΐου, 2023

Pralsetinib: Measures to Minimise Increased Risk for Tuberculosis

Ogkologos - 25 Μαΐου, 2023

Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer

Ogkologos - 24 Μαΐου, 2023

Patient-Reported Outcomes Support the Overall Benefit of Trastuzumab Deruxtecan for Patients...

Ogkologos - 24 Μαΐου, 2023

Cancer in My Community: Encouraging Cancer Screening in Estonia

Ogkologos - 23 Μαΐου, 2023

1...129130131...432 Σελίδα 130 από 432

MOST POPULAR

Favourable Response More Likely with Neoadjuvant Dual Immune Checkpoint Inhibitor Than...

11 Απριλίου, 2024

Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in...

27 Σεπτεμβρίου, 2024

FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell...

22 Ιουλίου, 2026

2022 ASCO Annual Meeting Research Round Up: Advances in Treating Genitourinary...

30 Ιουνίου, 2022

Φόρτωση περισσοτέρων

What is De-escalation Treatment in Cancer Research?

Could food improve cancer treatment? – That Cancer Conversation

Significant PFS Benefit in Patients with HR-positive, HER2-negative MBC Who Switched...

Use of Immune Checkpoint Inhibitors is Safe and Effective in Patients...

Reunión anual de la American Society of Clinical Oncology de 2023:...

ASCO Annual Meeting 2023: Improving Patients’ Lives Through Collaboration, Research, and...

Pralsetinib: Measures to Minimise Increased Risk for Tuberculosis

Drug Regimen Boosts Survival of People with Advanced Colorectal Cancer

Patient-Reported Outcomes Support the Overall Benefit of Trastuzumab Deruxtecan for Patients...

Cancer in My Community: Encouraging Cancer Screening in Estonia

MOST POPULAR

Favourable Response More Likely with Neoadjuvant Dual Immune Checkpoint Inhibitor Than...

Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in...

FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell...

2022 ASCO Annual Meeting Research Round Up: Advances in Treating Genitourinary...

HOT NEWS

Cancer in My Community: Providing Free Access to Cancer Care in...

FDA Approves Acalabrutinib with Bendamustine and Rituximab for Previously Untreated Mantle...

Change Your Thoughts, Change Your World

Mouse Study Links Immune Cells to Diarrhea Caused by Chemotherapy

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ